Baidu
map

中国儿童重症监护病房镇痛和镇静治疗专家共识(2018版)

2019-05-27 中华医学会儿科学分会急救学组 中华儿科杂志,2019,57(5):324-330.

镇痛和镇静治疗是重症患儿综合治疗的重要组成部分2013年巾华医学会儿科学分会急救学组、中华医学会急诊医学分会儿科学组和ffl国医师阱会重症医学医师分会儿科々业委贝会共同制定了“儿童重症监护治疗病房镇痛和镇静治疗专家共识(2013版)”,该共识的推⋯极大提高r我国儿童重症领域镇痛和镇静治疗技术的发展。2018年3个学术组织对2013年版共识进行更新修订,旨在进一步规范我国儿童重症监护病房镇痛和镇静治

中文标题:

中国儿童重症监护病房镇痛和镇静治疗专家共识(2018版)

发布日期:

2019-05-27

简要介绍:

镇痛和镇静治疗是重症患儿综合治疗的重要组成部分2013年巾华医学会儿科学分会急救学组、中华医学会急诊医学分会儿科学组和ffl国医师阱会重症医学医师分会儿科々业委贝会共同制定了“儿童重症监护治疗病房镇痛和镇静治疗专家共识(2013版)”,该共识的推⋯极大提高r我国儿童重症领域镇痛和镇静治疗技术的发展。2018年3个学术组织对2013年版共识进行更新修订,旨在进一步规范我国儿童重症监护病房镇痛和镇静治疗技术的实施。 

拓展指南:儿童相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188731, encodeId=5a251188e31df, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:27:23 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188728, encodeId=f0421188e283c, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:25:44 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069015, encodeId=729910690154f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:59:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913410, encodeId=22699134101c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201231/b0e9fa15281a4f7aa5a16cac48cea5b7/e25a5bd8719645f68c4ce3b5de51fc3c.jpg, createdBy=62ab5449166, createdName=屹起成长, createdTime=Sun Jan 03 21:06:42 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368720, encodeId=cd34368e20f7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jul 01 07:13:19 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2022-01-28 ms5000001611813221

    👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188731, encodeId=5a251188e31df, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:27:23 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188728, encodeId=f0421188e283c, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:25:44 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069015, encodeId=729910690154f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:59:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913410, encodeId=22699134101c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201231/b0e9fa15281a4f7aa5a16cac48cea5b7/e25a5bd8719645f68c4ce3b5de51fc3c.jpg, createdBy=62ab5449166, createdName=屹起成长, createdTime=Sun Jan 03 21:06:42 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368720, encodeId=cd34368e20f7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jul 01 07:13:19 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2022-01-28 ms5000001611813221

    👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188731, encodeId=5a251188e31df, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:27:23 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188728, encodeId=f0421188e283c, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:25:44 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069015, encodeId=729910690154f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:59:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913410, encodeId=22699134101c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201231/b0e9fa15281a4f7aa5a16cac48cea5b7/e25a5bd8719645f68c4ce3b5de51fc3c.jpg, createdBy=62ab5449166, createdName=屹起成长, createdTime=Sun Jan 03 21:06:42 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368720, encodeId=cd34368e20f7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jul 01 07:13:19 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2021-11-10 122b8c2dm25(暂无昵称)

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188731, encodeId=5a251188e31df, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:27:23 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188728, encodeId=f0421188e283c, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:25:44 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069015, encodeId=729910690154f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:59:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913410, encodeId=22699134101c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201231/b0e9fa15281a4f7aa5a16cac48cea5b7/e25a5bd8719645f68c4ce3b5de51fc3c.jpg, createdBy=62ab5449166, createdName=屹起成长, createdTime=Sun Jan 03 21:06:42 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368720, encodeId=cd34368e20f7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jul 01 07:13:19 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2021-01-03 屹起成长

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1188731, encodeId=5a251188e31df, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:27:23 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188728, encodeId=f0421188e283c, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c36452287, createdName=ms5000001611813221, createdTime=Fri Jan 28 02:25:44 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069015, encodeId=729910690154f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:59:16 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913410, encodeId=22699134101c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201231/b0e9fa15281a4f7aa5a16cac48cea5b7/e25a5bd8719645f68c4ce3b5de51fc3c.jpg, createdBy=62ab5449166, createdName=屹起成长, createdTime=Sun Jan 03 21:06:42 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368720, encodeId=cd34368e20f7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jul 01 07:13:19 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2019-07-01 thm112988

    0

Baidu
map
Baidu
map
Baidu
map